CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for National Pharmaceutical Industries Co SAOG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

National Pharmaceutical Industries Co SAOG
Road No 15, Al Rusayl Industrial Estate
P.O.Box 120
Phone: +968 24449090p:+968 24449090 Muscat, 124  Oman Fax: +968 24446431f:+968 24446431

This company is no longer actively traded on any major stock exchange.

Business Summary
National Pharmaceutical Industries Company SAOG is an Oman-based company, which is engaged in the manufacture of pharmaceutical products. The Company’s products include lipid lowering, cardio vascular, anti-bacterial, niche and mass, anti-allergic, non-steroidal anti-inflammatory, gastro intestinal, anti-diabetic, anti-depressant and analgesic antipyretic, among others. The Company’s facilities are spread over a 30,042.43 square meters plot of land, and consist of a non-beta lactum plant for the production of oral solids, liquids, drops, dry suspensions and sachets; a beta lactum plant, which produces capsules and dry suspension; a research and development laboratory, and a quality control laboratory.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201812/31/2017Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Independent Chairman of the Board Ghazi O.Al Zubaidi 4/29/2008 4/29/2008
Chief Executive Officer and Secretary to the Board of Directors G.Sridhar 3/19/2011 1/28/2009
Finance and Accounts Manager Gopal C.Mighty
10 additional Officers and Directors records available in full report.

Business Names
Business Name
National Pharmaceutical Industries
National Pharmaceutical Industries Co.
NPMI

General Information
Outstanding Shares: 99,762,054 (As of 9/30/2018)
Shareholders: 888
Stock Exchange: MSM
Fax Number: +968 24446431


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023